Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients

NCT06539663 is registered in ClinicalTrials.gov with Farwaniya Hospital as lead sponsor.

NCT NCT06539663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06539663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients
Lead sponsor
Farwaniya Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
April 10, 2022
Completion date
April 10, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal perforation, exposure keratitis, infectious keratitis